GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS (IST:GENIL) » Definitions » Change In Receivables

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Change In Receivables : ₺-693 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Change In Receivables?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's change in receivables for the quarter that ended in Dec. 2023 was ₺-98 Mil. It means Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Accounts Receivable increased by ₺98 Mil from Sep. 2023 to Dec. 2023 .

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's change in receivables for the fiscal year that ended in Dec. 2023 was ₺-693 Mil. It means Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Accounts Receivable increased by ₺693 Mil from Dec. 2022 to Dec. 2023 .

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Accounts Receivable for the quarter that ended in Dec. 2023 was ₺1,384 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Days Sales Outstanding for the three months ended in Dec. 2023 was 33.87.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's liquidation value for the three months ended in Dec. 2023 was ₺-462 Mil.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Change In Receivables Historical Data

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Change In Receivables Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial - -89.81 -97.76 -220.03 -692.74

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Dec18 Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.73 -273.61 -124.70 -196.71 -97.72

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺-693 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS  (IST:GENIL) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1383.861/3727.913*91
=33.87

2. In Ben Graham's calculation of liquidation value, Gen Ilac Veglik Urunlerinayi ve Ticaret AS's accounts receivable are only considered to be worth 75% of book value:

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=714.13-2853.69+0.75 * 1383.861+0.5 * 1278.903
=-462

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Business Description

Traded in Other Exchanges
N/A
Address
Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Headlines

No Headlines